We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTK icon
10326
Flotek Industries
FTK
$996M
$65K ﹤0.01%
5,111
-424
-8% -$6.14K
IGC icon
10327
PUT
IGC Pharma
IGC
$26.5M
$65K ﹤0.01%
41,700
+26,500
+174% +$39.2K
ORMP icon
10328
PUT
Oramed Pharmaceuticals
ORMP
$174M
$65K ﹤0.01%
+15,300
New +$49.8K
TRIB
10329
CALL
Trinity Biotech
TRIB
$7.56M
$65K ﹤0.01%
114
-41
-26% -$20.4K
OIG
10330
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$65K ﹤0.01%
746
-332
-31% -$14.2K
SIOX
10331
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$65K ﹤0.01%
23,300
-5,200
-18% -$15.1K
TDAY
10332
PUT
USA Today Co
TDAY
$1.33B
$64K ﹤0.01%
19,000
-9,500
-33% -$19.6K
GROW icon
10333
PUT
US Global Investors
GROW
$37.5M
$64K ﹤0.01%
+11,800
New +$40.5K
KRMD icon
10334
CALL
KORU Medical Systems
KRMD
$194M
$64K ﹤0.01%
+10,700
New +$59.9K
UONE icon
10335
Urban One Class A
UONE
$23.2M
$64K ﹤0.01%
1,527
-372
-20% -$18.8K
PHLT
10336
CALL
DELISTED
Performant Healthcare Inc
PHLT
$64K ﹤0.01%
+72,500
New +$74.1K
ATRS
10337
CALL
DELISTED
Antares Pharma, Inc.
ATRS
$64K ﹤0.01%
16,000
-1,900
-11% -$6.15K
CRNT icon
10338
PUT
Ceragon Networks
CRNT
$205M
$63K ﹤0.01%
22,500
+3,900
+21% +$9.99K
CRVO icon
10339
CervoMed
CRVO
$25.1M
$63K ﹤0.01%
1,061
+359
+51% +$21K
GORO icon
10340
CALL
Goldgroup Mining Inc.
GORO
$164M
$63K ﹤0.01%
21,600
+3,000
+16% +$9.31K
HGBL icon
10341
Heritage Global
HGBL
$35.8M
$63K ﹤0.01%
+23,562
New +$47.8K
MLSS icon
10342
Milestone Scientific
MLSS
$40.2M
$63K ﹤0.01%
+29,535
New +$52K
ETACW
10343
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$63K ﹤0.01%
+41,735
New +$45.4K
SBBP
10344
DELISTED
Strongbridge Biopharma plc.
SBBP
$63K ﹤0.01%
+25,978
New +$62.6K
RNET
10345
PUT
DELISTED
RigNet, Inc.
RNET
$63K ﹤0.01%
+10,700
New +$51.5K
AIFA
10346
All In FutureTech Alliance Inc
AIFA
$10.8M
$62K ﹤0.01%
+6,498
New +$46.7K
ALAR
10347
Alarum Technologies
ALAR
$13.7M
$62K ﹤0.01%
4,375
+2,589
+145% +$28.7K
EOLS icon
10348
Evolus
EOLS
$395M
$62K ﹤0.01%
18,359
+1,561
+9% +$5.86K
GSAT icon
10349
Globalstar
GSAT
$10.8B
$62K ﹤0.01%
12,188
+10,779
+765% +$52.1K
NNVC icon
10350
CALL
NanoViricides
NNVC
$39M
$62K ﹤0.01%
21,500
-9,800
-31% -$35.7K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.